Compare TRVI & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVI | RUN |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2019 | 2015 |
| Metric | TRVI | RUN |
|---|---|---|
| Price | $13.31 | $8.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 19 |
| Target Price | ★ $28.18 | $13.59 |
| AVG Volume (30 Days) | 1.5M | ★ 11.0M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.91 | ★ 113.35 |
| EPS | N/A | ★ 1.60 |
| Revenue | N/A | ★ $858,578,000.00 |
| Revenue This Year | N/A | $19.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.42 |
| Revenue Growth | N/A | ★ 12.97 |
| 52 Week Low | $9.82 | $6.78 |
| 52 Week High | $20.22 | $21.95 |
| Indicator | TRVI | RUN |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 48.05 |
| Support Level | $13.00 | $6.94 |
| Resistance Level | $13.55 | $9.17 |
| Average True Range (ATR) | 0.88 | 0.67 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 20.92 | 31.44 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.